ASX - Delayed Quote AUD

Bio-Gene Technology Limited (BGT.AX)

Compare
0.0490
-0.0030
(-5.77%)
At close: 4:10:45 PM GMT+11
Currency in AUD All numbers in thousands
Breakdown
TTM
6/30/2024
6/30/2023
6/30/2022
6/30/2021
Total Revenue
622.5070
--
595.0780
879.7760
573.1190
Gross Profit
622.5070
--
595.0780
879.7760
573.1190
Operating Expense
3,119.1650
3,119.1650
3,777.0720
3,853.3110
3,038.4630
Operating Income
-3,119.1650
-3,119.1650
-3,181.9940
-2,973.5350
-2,465.3440
Net Non Operating Interest Income Expense
87.0450
87.0450
85.9620
52.8640
37.7770
Other Income Expense
622.9410
622.9410
0.2500
6.4780
30.9660
Pretax Income
-2,409.1790
-2,409.1790
-3,095.7820
-2,914.1930
-2,396.2640
Net Income Common Stockholders
-2,409.1790
-2,409.1790
-3,095.7820
-2,914.1930
-2,396.2640
Basic EPS
-0.01
--
-0.02
-0.02
-0.02
Diluted EPS
-0.01
--
-0.02
-0.02
-0.02
Basic Average Shares
185,817.6550
--
167,768.2830
153,337.6560
137,232.9310
Diluted Average Shares
185,817.6550
--
167,768.2830
153,337.6560
137,232.9310
Net Income from Continuing & Discontinued Operation
-2,409.1790
-2,409.1790
-3,095.7820
-2,914.1930
-2,396.2640
Normalized Income
-2,409.1790
-2,409.1790
-3,095.7820
-2,914.1930
-2,396.2640
Interest Income
87.0450
87.0450
85.9620
52.8640
38.1140
Net Interest Income
87.0450
87.0450
85.9620
52.8640
37.7770
EBIT
-3,119.1650
-3,119.1650
-3,181.9940
-2,973.5350
-2,465.3440
EBITDA
-3,080.7840
-3,080.7840
-3,136.6980
-2,930.0200
-2,411.1220
Reconciled Depreciation
38.3810
38.3810
45.2960
43.5150
54.2220
Net Income from Continuing Operation Net Minority Interest
-2,409.1790
-2,409.1790
-3,095.7820
-2,914.1930
-2,396.2640
Normalized EBITDA
-3,080.7840
-3,080.7840
-3,136.6980
-2,930.0200
-2,411.1220
6/30/2021 - 11/28/2017

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers